A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Clinical trial NCT04775485 · RECRUITING
Trial details
- NCT number
- NCT04775485
- Sponsor
- Day One Biopharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2027-05-31
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.